PRESS RELEASE published on 04/21/2026 at 12:00, 5 months 23 days ago Lobe Sciences Ltd. Engages Massive Intelligence Pty Ltd for Investor Relations and Corporate Communications Services Lobe Sciences engages Massive Intelligence for investor relations and corporate communications services. Massive Intelligence to provide promotional services via social media, email, and press releases Investor Relations Biopharmaceutical Corporate Communications Lobe Sciences Massive Intelligence
BRIEF published on 04/20/2026 at 12:05, 5 months 24 days ago Lobe Sciences Completes Private Placement and Provides Corporate Update Private Placement Biopharmaceutical Investment Lobe Sciences Sickle Cell Treatment S-100 Development
BRIEF published on 04/20/2026 at 12:05, 5 months 24 days ago Lobe Sciences finalise un placement privé et publie une mise à jour de ses activités Placement Privé Investissement Biopharmaceutique Sciences Du Lobe Traitement De La Drépanocytose Développement Du S-100
PRESS RELEASE published on 04/20/2026 at 12:00, 5 months 24 days ago Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement and Provides Corporate Update Lobe Sciences Ltd. announces closing of non-brokered private placement offering to advance S-100 drug candidate for sickle cell disease treatment Private Placement Biopharmaceutical Sickle Cell Disease Lobe Sciences Ltd. S-100 Drug Candidate
BRIEF published on 04/11/2026 at 02:05, 6 months 3 days ago Lobe Sciences Ltd. Announces Private Placement for $950,000 Private Placement Funding Canada Securities Laws Regulatory Approvals
BRIEF published on 04/11/2026 at 02:05, 6 months 3 days ago Lobe Sciences Ltd. annonce un placement privé de 950 000 $ Financement Placement Privé Canada Approbations Réglementaires Lois Sur Les Valeurs Mobilières
PRESS RELEASE published on 04/11/2026 at 02:00, 6 months 3 days ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement Lobe Sciences Ltd. announces non-brokered private placement offering to raise approximately $950,000 for working capital and corporate expenses. Focus on neurology and psychiatry therapies Private Placement Psychiatry Neurology Thérapies Lobe Sciences Ltd.
BRIEF published on 03/25/2026 at 13:25, 6 months 20 days ago Lobe Sciences Ltd. Enhances Financial Stability Shareholder Value Debt Reduction Financial Stability Strategic Restructuring Subsidiary Model
BRIEF published on 03/25/2026 at 13:25, 6 months 20 days ago Lobe Sciences Ltd. renforce sa stabilité financière Valeur Actionnariale Réduction De La Dette Restructuration Stratégique Stabilité Financière Modèle De Filiale
PRESS RELEASE published on 03/25/2026 at 13:20, 6 months 20 days ago Lobe Sciences Ltd. Reports Improved Financial Position and Strategic Update Lobe Sciences Ltd. significantly improves financial position: liabilities down 81%, cash up 24x, net working capital up $6.1M, outstanding warrants down 70%, and strengthened the balance sheet and capital structure Financial Position Balance Sheet Capital Structure Strategic Update Lobe Sciences Ltd.
Published on 10/14/2026 at 15:40, 4 hours 39 minutes ago Galway Metals Announces Closing of $14 Million Brokered Private Placement Led by Michael Gentile
Published on 10/14/2026 at 15:00, 5 hours 19 minutes ago Route1 Provides Operating and Market Update; Outlines Q4 2026 Priorities
Published on 10/14/2026 at 15:00, 5 hours 19 minutes ago Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer
Published on 10/14/2026 at 14:50, 5 hours 29 minutes ago AIAI Holdings to Present at the 20th Annual LD Micro Main Event
Published on 10/14/2026 at 14:30, 5 hours 49 minutes ago Boron One Holdings Inc. Announces Positive Preliminary Economic Assessment (PEA) for Its Piskanja Boron Project
Published on 10/14/2026 at 19:32, 47 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2026: Earnings below prior year – net sales up – forecast confirmed
Published on 10/14/2026 at 19:05, 1 hour 14 minutes ago Bulgin Introduces 6000 Series Hybrid Buccaneer Connectors for Power and Signal Connectivity
Published on 10/14/2026 at 19:00, 1 hour 19 minutes ago Informations relatives à l’augmentation de capital
Published on 10/14/2026 at 18:43, 1 hour 36 minutes ago Jean-Marc Bellaiche to become new CEO of the DOUGLAS Group - Sander van der Laan to retire
Published on 10/14/2026 at 18:00, 2 hours 19 minutes ago CIS : Chiffre d’affaires du 3ème trimestre 2026 supérieur aux attentes : accélération de la croissance et visibilité renforcée.
Published on 10/14/2026 at 18:00, 2 hours 19 minutes ago CIS : Q3 2026 revenue higher than expected: accelerated growth and increased visibility.
Published on 10/14/2026 at 17:40, 2 hours 39 minutes ago Mersen obtient la certification internationale Living Wage pour son engagement en faveur du bien-être de ses collaborateurs
Published on 10/14/2026 at 17:40, 2 hours 39 minutes ago Mersen’s commitment to employee well-being earns it international Living Wage certification